XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings per Share (EPS) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Earnings per Share (EPS) | Earnings per Share (EPS) The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(In thousands, except per share amounts) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Net income |  | $ | 164,215 |  |  | $ | 176,175 |  |  | $ | 534,987 |  |  | $ | 561,503 |
Basic weighted average shares outstanding |  | 97,400 |  |  | 105,266 |  |  | 100,086 |  |  | 105,539 |
Dilutive effect of nonvested shares |  | 1,119 |  |  | 1,288 |  |  | 1,069 |  |  | 1,161 |
Diluted weighted average shares outstanding |  | 98,519 |  |  | 106,554 |  |  | 101,155 |  |  | 106,700 |
Basic earnings per share |  | $ | 1.69 |  |  | $ | 1.67 |  |  | $ | 5.35 |  |  | $ | 5.32 |
Diluted earnings per share |  | $ | 1.67 |  |  | $ | 1.65 |  |  | $ | 5.29 |  |  | $ | 5.26 |
There were 5,847 and 2,842 antidilutive shares for the three months ended September 30, 2025 and 2024, respectively, and 47,223 and 69,021 antidilutive shares for the nine months ended September 30, 2025 and 2024, respectively Nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. The 2025, 2024 and 2023 performance-based share awards vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period. The following table summarizes the performance-based shares issuable if the reporting date was the end of the contingency period:
|  | 2025 Performance-Based Grants |  | 2024 Performance-Based Grants |  | 2023 Performance-Based Grants |  | 2022 Performance-Based Grants
Reporting Date |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued
September 30, 2025 |  | 200% |  | 100% |  | 134% |  | 67% |  | 197% |  | 98.5% |  | (1) |  | (1)
September 30, 2024 |  |  |  |  |  | 181% |  | 90.5% |  | 200% |  | 100% |  | 200% |  | 100%
(1) The 2022 performance based awards vested at 168% relative to target on March 1, 2025.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration